BREAKING NEWS: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer (read more here).

Get the Prostate Cancer Patient Guide, available as a free emailed pdf.

*

Loading...

Go here to learn more or to get a mailed copy.

Contact Us
Press
Blog

Prostate Cancer Foundation

Donate Fundraise

About Prostate Cancer
Close
- About Prostate Cancer
Patient Resources
Close
- Patient Resources
News
Close
- All News
- - News by Topic
  - Industry News
  - PCF in the News
  - Press Releases
- - Sign up for NewsPulse today and get groundbreaking information.
    Monthly Newsleter
- - Get the latest updates in health & wellness research.
    Monthly Newsletter
Science & Impact
Close
- Science & Impact
Take Action
Close
- Take Action
- - Help Fund a Cure
  - Donate
  - Become a Monthly Donor
  - Send an eCard
  - Other Ways to Give
  - Memorial Donations
  - Donation FAQs
  - Stay Informed
- - Why Give to PCF
    Why Give
  - Send an eCard
    Send an eCard
About Us
Close
- About Us

Contact Us

Prostate Cancer Foundation

Close

Donate Fundraise

About Prostate Cancer
Patient Resources
News
Science & Impact
Take Action
About Us
Contact Us Press Blog

Home » Bio » Board Members » Peter T. Grauer

Peter T. Grauer

Board Member

About Peter T. Grauer

View All Board Members here.

Chairman
Bloomberg LP

82 cents of every dollar donated goes to our prostate cancer research mission

82%

Join the fight against prostate cancer today. Donate

Prostate Cancer Foundation
1250 Fourth Street
Santa Monica, CA 90401
1.800.757.CURE (2873)
Main 310.570.4700

Prostate Cancer Foundation
1250 Fourth Street
Santa Monica, CA 90401
1.800.757.CURE (2873)
Main 310.570.4700

About Prostate Cancer
Patient Resources
News
Science & Impact
Take Action
About Us

Contact Us
Careers
Press
Guides
Blog
Sitemap

Receive PCF news in your inbox

*Email:

Loading...

The Prostate Cancer Foundation is a 501(c)(3) charitable organization.

EIN #95-4418411

Terms of use
Privacy Policy

© Prostate Cancer Foundation, 2022

By using this website, you consent to our use of cookies. For more information, visit our Privacy Policy